This group of studies is looking at the following drug side effects in IBD.
-
- Thiopurine included myelosuppression
- Thiopurine induced pancreatitis
- Anti-TNF induced demyelination
- PPI induced interstitial nephritis
- Thiopurine Induced Liver Injury
- Sulfasalazine Induced Neutropaenia
- Thiopurine Hypersensitivity Reaction
- Immunogenicity to biologic drugs in IBD
- Anti-TNF induced adverse skin reactions in IBD
The study protocol is below:
PRED4 Protocol version 7.1 final dated 13th February 2018
The new CRF for Immunogenicity to biology drugs in IBD:
The new CRF for Anti-TNF induced adverse skin reactions in IBD:
The CRF for the Thiopurine Hypersensitivity Reaction:
The CRF for the PPI induced Interstitial Nephritis:
The CRF for the Sulfasalazine induced neutropenia in IBD and Rheumatoid Arthritis:
The CRF for the Thiopurine induced Liver Injury:
The CRF for the Thiopurine induced Leucopenia:
The CRF for the Thiopurine induced Pancreatitis:
The CRF for the Anti-TNF alpha induced demyelination in IBD and other inflammatory Diseases:
Participant questionnaire TEMPLATE v2 March 2015
The HINTS and TIP documents is a very useful tool to find patients:
PRED4 inc criteria & Tips 2018
Do you have inflammatory Bowel disease patient advert.
For any further information please contact Claire Bewshea 01392 406850 or email claire.bewshea@nhs.net